CJC-1295 DAC 5mg

Product Name: CJC-1295 DAC 5mg
Compound: CJC-1295 with DAC
Quantity: 5mg
Product Category: Research peptide
Peptide Type: GHRH-related synthetic peptide
Research Area: GHRH receptor and endocrine research
Intended Application: Laboratory and analytical research
Format: Refer to current product specifications
Documentation: Batch-specific documentation where available
Purity: Refer to the applicable Certificate of Analysis
Storage: Follow product-specific documentation
Use: Research use only

$55.00

CJC-1295 DAC 5mg Research Peptide

CJC-1295 DAC 5mg is a research-oriented synthetic peptide material supplied for qualified laboratory, analytical, educational, and scientific research applications. CJC-1295 with DAC has been investigated in research involving growth hormone-releasing hormone (GHRH) receptor signaling, peptide-receptor interactions, endocrine pathways, peptide stability, and molecular pharmacology.

The DAC designation refers to the Drug Affinity Complex, a structural modification associated with extended interaction with serum albumin. This distinguishes CJC-1295 DAC from CJC-1295 without DAC and makes the two forms relevant to comparative peptide research.

CJC-1295 DAC 5mg is presented strictly as a research material and is not marketed as a pharmaceutical, dietary supplement, or therapeutic product.

For Research Use Only. Not for Human Consumption.

CJC-1295 DAC 5mg Product Information

Product Name: CJC-1295 DAC 5mg
Compound: CJC-1295 with DAC
Quantity: 5mg
Product Category: Research peptide
Peptide Type: GHRH-related synthetic peptide
Research Area: GHRH receptor and endocrine research
Intended Application: Laboratory and analytical research
Format: Refer to current product specifications
Documentation: Batch-specific documentation where available
Purity: Refer to the applicable Certificate of Analysis
Storage: Follow product-specific documentation
Use: Research use only

Researchers should review the applicable product specifications and batch documentation before incorporating CJC-1295 DAC into a laboratory workflow.

What Is CJC-1295 DAC?

CJC-1295 DAC is a synthetic peptide associated with growth hormone-releasing hormone (GHRH) research. The DAC component is designed to alter the peptide’s interaction with albumin and consequently its pharmacokinetic characteristics.

From a research perspective, this makes CJC-1295 DAC useful for investigating how peptide structure and molecular modifications can influence stability, receptor interactions, circulation characteristics, and biological signaling in experimental systems.

CJC-1295 DAC research is relevant to peptide chemistry, receptor biology, endocrine signaling, molecular pharmacology, and analytical research.

CJC-1295 DAC and GHRH Research

GHRH is a naturally occurring hypothalamic peptide involved in growth hormone regulation. The GHRH receptor is therefore an important research target in endocrinology and molecular biology.

Research involving CJC-1295 DAC may investigate:

  • GHRH receptor interactions
  • Peptide-receptor binding
  • Growth hormone-related signaling
  • Endocrine pathways
  • Molecular pharmacology
  • Peptide chemistry
  • Albumin-binding characteristics
  • Peptide stability
  • Signal transduction
  • Structure-function relationships
  • Analytical characterization

The specific research application should be determined by the qualified laboratory conducting the study.

What Does DAC Mean?

DAC stands for Drug Affinity Complex.

The DAC modification is an important distinguishing characteristic of CJC-1295 DAC. Research has investigated how the modification affects the peptide’s interaction with serum albumin and influences its pharmacokinetic properties.

This is different from CJC-1295 W/O DAC, which does not contain the Drug Affinity Complex.

Researchers comparing these two materials should verify the exact identity and specifications of each compound through appropriate analytical documentation.

CJC-1295 DAC vs. CJC-1295 W/O DAC

The two product names refer to distinct research materials.

CJC-1295 DAC contains the Drug Affinity Complex and has been studied for its altered albumin-binding and pharmacokinetic characteristics.

CJC-1295 W/O DAC does not contain the DAC modification and is investigated as a different form of the peptide.

The distinction is important for research involving:

  • Molecular structure
  • Peptide stability
  • Albumin interaction
  • Receptor activity
  • Pharmacokinetic research
  • Structure-function relationships
  • Analytical characterization

Researchers should always verify the specific product identity before beginning an experiment.

CJC-1295 DAC 5mg Research Applications

Peptide Chemistry

Researchers may examine the molecular structure, amino-acid composition, purity, stability, and chemical characteristics of CJC-1295 DAC.

Receptor Biology

CJC-1295 DAC can be investigated in laboratory systems designed to examine GHRH receptor interactions.

Endocrine Research

Researchers may study molecular pathways associated with GHRH and growth hormone signaling.

Albumin-Binding Research

The DAC modification provides an opportunity to investigate peptide-albumin interactions and their relationship to peptide behavior in experimental systems.

Molecular Pharmacology

Laboratories may examine ligand-receptor interactions, signaling mechanisms, molecular activity, and structure-function relationships.

Analytical Research

Research laboratories may characterize peptide identity, purity, concentration, stability, and other measurable properties using appropriate analytical methods.

CJC-1295 DAC Research Format

CJC-1295 DAC 5mg may be supplied as a research peptide material in a defined physical form. Researchers should consult the current product documentation for the exact format, storage requirements, and handling information.

Laboratory evaluation may include:

  • Peptide identity
  • Amino-acid composition
  • Chemical purity
  • Molecular characterization
  • Stability
  • Albumin-binding studies
  • Receptor interaction studies
  • Batch consistency
  • Analytical profile

Researchers should use established laboratory procedures appropriate to the material and experimental design.

Certificate of Analysis

A Certificate of Analysis (COA) can provide important batch-specific information when evaluating CJC-1295 DAC research material.

Depending on the applicable batch, documentation may include:

  • Product identification
  • Peptide identification
  • Batch or lot number
  • Analytical testing
  • Reported purity
  • Testing date
  • Applicable specifications
  • Laboratory test results

Researchers should review the COA associated with the specific batch being evaluated rather than assuming that analytical information from another batch applies to the current material.

Research Peptide Quality Considerations

When evaluating CJC-1295 DAC 5mg, laboratories may consider:

  • Compound identity
  • Presence of DAC
  • Peptide sequence
  • Batch traceability
  • Analytical documentation
  • Reported purity
  • Product format
  • Packaging
  • Storage requirements
  • Testing information
  • Applicable regulatory requirements

PeptidesChemSupplier.com provides structured research-product information to help qualified laboratories evaluate peptide materials according to their scientific and analytical requirements.

CJC-1295 DAC Research Peptide Supplier

Researchers searching for this material may use several related terms, including CJC-1295 DAC 5mg, CJC-1295 DAC research peptide, CJC-1295 with DAC research peptide, CJC-1295 research compound, CJC-1295 DAC laboratory material, and GHRH research peptide.

Using the full product designation helps researchers distinguish the DAC form from CJC-1295 without DAC.

International CJC-1295 DAC Research

Researchers in different geographic markets may use location-specific search terms when looking for CJC-1295 DAC research materials.

Relevant searches can include:

  • CJC-1295 DAC 5mg research peptide USA
  • CJC-1295 DAC research peptide USA
  • CJC-1295 with DAC research peptide USA
  • CJC-1295 DAC research peptide UK
  • CJC-1295 with DAC research peptide UK
  • CJC-1295 DAC research compound Canada
  • CJC-1295 with DAC research peptide Canada
  • CJC-1295 DAC research peptide Europe
  • CJC-1295 with DAC research peptide Europe
  • CJC-1295 DAC research peptide Australia
  • CJC-1295 with DAC research peptide Australia
  • CJC-1295 DAC research peptide India
  • CJC-1295 with DAC research peptide India

Availability, import requirements, customs rules, and regulatory requirements can differ between jurisdictions. Customers and laboratories are responsible for determining the requirements applicable to research materials in their location.

Geographic terminology is included to help researchers locate relevant research information and does not imply authorization for human use in any particular country.

CJC-1295 DAC and Scientific Research

Scientific research involving CJC-1295 DAC has investigated its interaction with GHRH receptor systems and the effects of the DAC modification on peptide pharmacokinetic characteristics.

The compound has also been examined as a research tool for understanding how structural modifications can influence peptide stability, albumin binding, receptor activity, and biological signaling.

Researchers should evaluate primary scientific literature, experimental methodology, and study limitations when interpreting findings involving CJC-1295 DAC.

Frequently Asked Questions About CJC-1295 DAC 5mg

What is CJC-1295 DAC 5mg?

CJC-1295 DAC 5mg is a research-oriented synthetic peptide material associated with GHRH receptor and endocrine research.

What does DAC mean in CJC-1295 DAC?

DAC refers to the Drug Affinity Complex, a modification associated with the peptide’s interaction with serum albumin.

What is the difference between CJC-1295 DAC and W/O DAC?

CJC-1295 DAC contains the Drug Affinity Complex, while CJC-1295 W/O DAC does not. The distinction is relevant to research involving molecular structure, stability, albumin interaction, and pharmacokinetic characteristics.

What research areas are associated with CJC-1295 DAC?

Research may include GHRH receptor biology, peptide chemistry, endocrine signaling, albumin-binding research, molecular pharmacology, peptide stability, and analytical characterization.

Is CJC-1295 DAC 5mg intended for human use?

No. The material is presented strictly as research material and is not intended for human consumption, self-administration, or therapeutic use.

Does CJC-1295 DAC 5mg have a COA?

Batch-specific analytical documentation may be available. Researchers should review the Certificate of Analysis associated with the specific batch being evaluated.

How should CJC-1295 DAC 5mg be stored?

Storage and handling should follow the product-specific documentation supplied with the research material and the procedures established by the relevant laboratory.

Research Use Disclaimer

CJC-1295 DAC 5mg is supplied strictly for research, analytical, educational, and laboratory purposes.

It is not intended for human consumption, self-administration, medical use, therapeutic use, diagnostic use, veterinary use, or use as a food additive.

The information presented on this page is provided for scientific and educational purposes and should not be interpreted as medical advice or as a claim that CJC-1295 DAC can diagnose, treat, cure, or prevent any disease or medical condition.

Researchers, institutions, and purchasers are responsible for complying with applicable laws, regulations, import requirements, institutional policies, and laboratory safety requirements governing research materials in their jurisdiction.

Product specifications, analytical information, availability, and documentation may vary by batch. Researchers should refer to the applicable product documentation and Certificate of Analysis for the specific material being evaluated.